Braindex proudly announces that its patent has been granted in Europe and the United States. ​It not only validates the novelty and uniqueness of our NIRS sensor technology, but also consolidates our position as a leading player in the brain-centered approach to anesthesia.​ As we look ahead, our company remains committed to pushing the boundaries of innovation, exploring […]
NIRS patent european and US​ Read More »
We are proud to announce the completion of the Braindex TAVI protocol and the establishment of the clinical database used to build the ARGOS cerebral NIRS algorithms. This achievement is distinguished by the fact that the ARGOS NIRS algorithms are the first of their kind to be calibrated under surgical conditions, during induced circulatory arrest
TAVI protocol in private hospital Jacques Cartier cardiology​ Read More »
Great news! Braindex is awarded in the inaugural List of Innovative Companies in North of France, evaluated by Eurasanté. We’re thrilled to be part of a community that recognizes innovation as a vital asset for development, and we take pride in this achievement.​
12-2023 : Palmarès des Entreprises Innovantes en Hauts-de-France​ Read More »
